-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Initiates Coverage On Tarsus Pharmaceuticals with Outperform Rating, Announces Price Target of $100

Benzinga·11/20/2025 16:10:08
Listen to the news
Mizuho analyst Graig Suvannavejh initiates coverage on Tarsus Pharmaceuticals (NASDAQ:TARS) with a Outperform rating and announces Price Target of $100.